GW Pharma's sole marketed drug Sativex is currently approved in 23 countries for the treatment of spasticity due to multiple sclerosis (MS)
DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentag...
Orexigen Therapeutics rose on positive interim data from the Light Study on Contrave.
Novo Nordisk received a positive opinion from the CHMP under the EMA regarding NovoRapid PumpCart
Biogen Idec was a big mover last session, with shares rising over 13%.
Affymetrix, Inc. announces the availability of a multi-genome pathogen microarray, designed by the Food and Drug Administration’s Center for Food Safety and Applied Nutrition and built by Affymetrix, for the detection and identification of pathogenic E.
Affymetrix Inc. and Life Technologies Corp.’s Navigenics unit didn’t infringe a patent owned by Massachusetts Institute of Technology and E8 Pharmaceuticals LLC over a system to analyze genes, the U.S. ...
A federal appeals court affirm the judgment of noninfringement in favor of Affymetrix and Navigenics in their dispute with E8 Pharmaceuticals and The Massachusetts Institute of Technology.
Shares of Affymetrix have been on fire over the past year despite lacking any real fundamental fuel. Will this hot stock keep rising, or is it destined to crash and burn?
Affymetrix' both earnings and revenues beat the Zacks Consensus Estimate.
Franklin R. Witney Good afternoon, and thank you for joining us. Before I review our commercial and operational performance for the third quarter, I'd like to reiterate our goals for the second phase of ...